Brief: SynAct Pharma To Buy Back Own Shares
Jan 12 (Reuters) - SynAct Pharma AB SYNACT.ST: SAID ON FRIDAY RESOLVED ON REPURCHASE OF OWN SHARES MAXIMUM AGGREGATE ACQUISITION AMOUNT IS SEK 5 MILLION REDUCTION OF SHARE CAPITAL IS INTENDED TO BE OFFSET BY CORRESPONDING BONUS ISSUE Source text for Workspace: ID:nMFN5JGgJM Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development